PARTICIPATION OF MEMBRANE CALCIUM CHANNELS IN ERYTHROPOIETIN-INDUCED ENDOTHELIAL CELL MIGRATION

MALTANERI, ROMINA E.; NESSE, ALCIRA B.; SCHIAPPACASSE, AGUSTINA; VITTORI, DANIELA C.; CHAMORRO, MARÍA E.; MALTANERI, ROMINA E.; NESSE, ALCIRA B.; SCHIAPPACASSE, AGUSTINA; VITTORI, DANIELA C.; CHAMORRO, MARÍA E.

EUROPEAN JOURNAL OF CELL BIOLOGY

ELSEVIER GMBH

Año: 2018 vol. 97 p. 411 - 421

0171-9335

Calcium (Ca2+) plays an important role in angiogenesis, as it activates the cell migration machinery. Different proangiogenic factors have been demonstrated to induce transient Ca2+ increases in endothelial cells. This has raised interest in the contribution of Ca2+ channels to cell migration, and in a possible use of channel-blocking compounds in angiogenesis-related pathologies. We have investigated the ability of erythropoietin (Epo), a cytokine recently involved in angiogenesis, to induce Ca2+ influx through different types of membrane channels in EA.hy926 endothelial cells. The voltage-dependent Ca2+ channel antagonists amlodipine and diltiazem inhibited an Epo-triggered transient rise in intracellular Ca2+, similarly to a specific inhibitor (Pyr3) and a blocking antibody against the transient potential calcium channel 3 (TRPC3). Unlike diltiazem, amlodipine and the TRPC3 inhibitors prevented the stimulating action of Epo in cell migration and in vitro angiogenesis assays. Amlodipine was also able to inhibit an increase in endothelial cell migration induced by Epo in an inflammatory environment generated with TNF-α. These results support the participation of Ca2+ entry through voltage-dependent and transient potential channels in Epo-driven endothelial cell migration, highlighting the antiangiogenic activity of amlodipine.